CS
MOR

Credit Suisse’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Credit Suisse’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,765
Closed -$13K – 4380
2022
Q2 		$13K Buy
+2,765
New +$15.3K ﹤0.01% 3711

Other funds holding MOR

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Credit Suisse's MOR Position: Q3 2022 in Review

Credit Suisse sold out of MorphoSys AG American Depositary Shares (MOR) in Q3 2022, closing a stake of 2,765 shares — an estimated $13K sold.

Credit Suisse first reported a position in MOR in Q2 2022 and held it in 1 quarter. The position peaked at $13K in Q2 2022. 23 funds tracked by Wall St. Rank hold MOR as of Q3 2022.

  • Credit Suisse reported no remaining MorphoSys AG American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 2,765 MorphoSys AG American Depositary Shares shares in Q3 2022, an estimated $13K.
  • Credit Suisse first reported a position in MorphoSys AG American Depositary Shares in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's MorphoSys AG American Depositary Shares position peaked at $13K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.